Complete regression of a suprasellar secondary mass in a patient with low-grade non-Hodgkin's lymphoma (NHL) treated with 2-chlorodeoxyadenosine (CdA)
deCataldo
F
F
Baudo
F
F
Ottonelli
C
C
Italia
C
C
Valdagni
R
R
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary; D002423:Cause of Death; D017338:Cladribine / Q000627:therapeutic use*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008875:Middle Aged; D012074:Remission Induction; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents; D017338:Cladribine